Literature DB >> 2557379

Biological response modifier enhances the activity of natural killer cell against human cytomegalovirus-infected cells.

T Murayama1, S Natsuume-Sakai, B Xu, T Furukawa, C R Rinaldo.   

Abstract

Peripheral blood lymphocytes (PBL) from two human cytomegalovirus (CMV)-seronegative donors and eight CMV-seropositive donors were cultured for 3 days with or without the biological response modifier OK-432 and examined for lysis of K562 cells and CMV-infected MRC-5 cells. OK-432-stimulated PBL exhibited significantly greater natural killer (NK) activity than did unstimulated PBL. There was no difference in activity of NK cells in PBL prepared from CMV-seronegative and -seropositive donors. Antibody-complement depletion studies suggested that OK-432-stimulated NK activity was associated with Leu-7-positive cells. The ability of OK-432 to sustain the NK activity in PBL was decreased when the CD4-positive population of lymphocytes was eliminated by antibody-complement depletion prior to OK-432 stimulation. The ability of OK-432 to sustain the NK activity of PBL was also significantly decreased in the presence of monoclonal antibody against recombinant human interleukin-2. The results suggest that the activity of human NK cells against K562 and CMV-infected MRC-5 target cells can be sustained in vitro by OK-432-stimulated T-helper cells and that the effect of the T-helper cells is mediated, at least in part, by interleukin-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557379     DOI: 10.1002/jmv.1890290206

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  1 in total

1.  Antitumor activity of oenothein B, a unique macrocyclic ellagitannin.

Authors:  K Miyamoto; M Nomura; M Sasakura; E Matsui; R Koshiura; T Murayama; T Furukawa; T Hatano; T Yoshida; T Okuda
Journal:  Jpn J Cancer Res       Date:  1993-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.